Open for inclusion

A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma

Cancer type: Lymphoma

Phase: II

Principal Investigator: Joergensen Judit

Country: DK

Keywords: Denmark, Aarhus, Århus, high risk, diffuse, large B-cell lymphoma

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03003520